BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Lovastatin
,
rs4950928
,
FXYD4
,
glucose metabolic process
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
transformed cells
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Revealing the Cell Structure and Formation of Bamboo with Confocal Raman Microscopy].
Fourier transform infrared spectroscopy for the distinction of MCF-7 cells treated with different co…
SV40 Large T Antigen Disrupts Embryogenesis of Canine and Porcine Somatic Cell Nuclear Transfer Embr…
The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.
Cell-Penetrating Cross-β Peptide Assemblies with Controlled Biodegradable Properties.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment
Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin L…
Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Smal…
Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell N…
Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immuno…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ